MAPT and Alzheimer disease: We then tested if the PST-001 DYRK1A inhibitor could rectify these AD model phenotypes and showed DYRK1A inhibition was able to increase total sleep of human Tau or mnb clock overexpressing flies (Figure 5A) to wild type levels, thereby demonstrating full pharmacological rescue.